Bryce Beard
Radiation Oncology · Alexandria, LANPI 1356798086
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $2,100 of the $2,506 with a category attached, or 83.8%. AstraZeneca accounts for 83.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $2,100 and has fallen 94.2% since, to $121 in 2025.
Across 11 payments — averaging $227.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Varian Medical Systems, Inc.$153
- Caris MPI, Inc.$121
- Viewray Technologies Inc$60
- Boston Scientific$57
- Bayer$14
What the payments were for
- Consulting fees$2,10084%
- Food & beverage$40616%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 4 | $2,100 |
| Varian Medical Systems, Inc. | 2 | $153 |
| Caris MPI, Inc. | 1 | $121 |
| Viewray Technologies Inc | 1 | $60 |
| Boston Scientific | 2 | $57 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMFINZI$1,575
- TAGRISSO$525
- MI CANCER SEEK$121
- Radiation Oncology$113
How this compares
$2,506 in reported general payments places this provider in the 85th percentile of 58 radiation oncology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 17 | $337 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 20 | $245 |
| Tamsulosin Hcl | 14 | $135 |
| Duloxetine Hcl | 15 | $130 |
| Lorazepam | 13 | $8 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Alexandria
- Lawrence MenacheAlexandria$3K
- Natalie Alphonse SullivanAlexandria$515
- Chiachien WangShreveport$31K
- James RussoLafayette$20K
- Lane RosenShreveport$10K
- Konstantin KovtunBaton Rouge$3K
- James MazeLake Charles$3K
- Christophe MarquesNew Orleans$3K
- Troy RichardsShreveport$3K
- Andrew ElsonBaton Rouge$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.